Answers are grounded in this paper and cite their sources.
Free thiol content and charge heterogeneity are critical quality attributes for therapeutic antibodies, impacting stability, activity, and batch consistency. Currently, no single analytical method can simultaneously profile both attributes in a rapid, accurate, and comprehensive manner, especially with the ability to distinguish between exposed and buried free thiols. Here, we present a novel charged-tagging strategy using N-2-aminoethyl maleimide, a thiol-specific derivatizing agent that introduces a defined positive charge upon conjugation. This enables clear separation by ion-exchange chromatography while preserving the inherent capability to resolve charge heterogeneity. For exposed free thiols, direct labeling provides excellent resolution and quantitative recovery. For buried or partially buried thiols, a mild structural-unfolding step enables quantitative derivatization while preserving native charge profiles. Implemented on a standard high performance liquid chromatography-ultraviolet detector (HPLC-UV) system, this platform delivers the first integrated, rapid, accurate and comprehensive-compatible approach for simultaneous free thiol and charge heterogeneity profiling. Our work significantly expands the detection ability of ion-exchange chromatography and offers a practical solution for mAb process development, optimization, and routine quality control.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: